GTBP Earnings GT Biopharma, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | -0.11 | 2026-05-15 | 10-Q |
| FY 2025 | 2025-12-31 | -6.68 | 2026-03-02 | 10-K |
| FY 2025 | 2025-09-30 | -8.90 | 2026-03-02 | 10-K |
| FY 2025 | 2025-06-30 | -12.12 | 2026-03-02 | 10-K |
| Q1 2026 | 2025-03-31 | -0.33 | 2026-05-15 | 10-Q |
| FY 2025 | 2024-12-31 | -6.94 | 2026-03-02 | 10-K |
| Q3 2025 | 2024-09-30 | -5.28 | 2025-11-14 | 10-Q |
| Q2 2025 | 2024-06-30 | -3.86 | 2025-08-14 | 10-Q |
| Q1 2025 | 2024-03-31 | -1.64 | 2025-05-15 | 10-Q |
| FY 2024 | 2023-12-31 | -5.64 | 2025-02-21 | 10-K |
| Q3 2024 | 2023-09-30 | -3.47 | 2024-11-14 | 10-Q |
| Q2 2024 | 2023-06-30 | -1.68 | 2024-08-14 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.21 | 2024-05-15 | 10-Q |
| FY 2023 | 2022-12-31 | -19.66 | 2024-03-26 | 10-K |
| Q3 2023 | 2022-09-30 | -0.48 | 2023-11-01 | 10-Q |
| Q2 2023 | 2022-06-30 | -0.26 | 2023-08-07 | 10-Q |
| Q1 2020 | 2020-03-31 | -0.02 | 2020-05-15 | 10-Q |
| Q1 2020 | 2019-03-31 | -0.09 | 2020-05-15 | 10-Q |
| FY 2018 | 2018-12-31 | -5.16 | 2019-03-29 | 10-K |
| Q3 2018 | 2018-09-30 | -5.09 | 2018-11-14 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.